Michael Y. He

Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

Kit I. Tong, Sharon Yoon, Keren Isaev et al. · Clinical Cancer Research · 2021 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor–microenvironment interactions

Peiran Su, Yin Liu, Tianyi Chen et al. · Nature Genetics · 2024 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17

Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8

Yufeng Xiao, Nikee Awasthee, Yi Liu et al. · Journal of Medicinal Chemistry · 2024 · 16 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Identification of genetic subtypes in follicular lymphoma

Victoria Shelton, Rajesh Detroja, Ting Liu et al. · Blood Cancer Journal · 2024 · 13 citations · Full text

Medicine, Genetics, Oncology +17

Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy

Michael Y. He, Michael M. Halford, Ruofei Liu et al. · Communications Biology · 2021 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +17